Carisma Therapeutics, Inc.
Price Action
Technical Summary
DOWNTRENDCarisma Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 98), indicating clear outperformance against the broad market. Earnings growth of 445% provides fundamental context to the price action. Investors should exercise caution due to high volatility (243% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.01 | -14.49% | BELOW |
| 50 SMA | $0.01 | -24.36% | BELOW |
| 100 SMA | $0.02 | -74.57% | BELOW |
| 150 SMA | $0.03 | -81.27% | BELOW |
| 200 SMA | $0.07 | -91.73% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CARM in an uptrend right now?
CARM has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is CARM overbought or oversold?
CARM's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is CARM outperforming the market?
CARM has a Relative Strength (RS) Rating of 98 out of 99. Yes, CARM is a market leader, outperforming 98% of all stocks over the past 12 months.
Where is CARM in its 52-week range?
CARM is trading at $0.01, which is 1% of its 52-week high ($0.56) and 1% above its 52-week low ($0.00).
How volatile is CARM?
CARM has a Beta of -0.52 and 52-week volatility of 243%. It's less volatile than the S&P 500 - generally more stable.